{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:02Z","timestamp":1781650682311,"version":"3.54.5"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["IDS-TILDA-2021-001"],"award-info":[{"award-number":["IDS-TILDA-2021-001"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["IDS-TILDA-2021-001"],"award-info":[{"award-number":["IDS-TILDA-2021-001"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015442","name":"Global Brain Health Institute","doi-asserted-by":"publisher","award":["UK-20-641398"],"award-info":[{"award-number":["UK-20-641398"]}],"id":[{"id":"10.13039\/100015442","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer's Society Fellowship","award":["AS-CP-118-0020"],"award-info":[{"award-number":["AS-CP-118-0020"]}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2022_EKEA.133"],"award-info":[{"award-number":["2022_EKEA.133"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2022_EKEA.133"],"award-info":[{"award-number":["2022_EKEA.133"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2022_EKEA.133"],"award-info":[{"award-number":["2022_EKEA.133"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2022_EKEA.133"],"award-info":[{"award-number":["2022_EKEA.133"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Norwegian National Centre for Ageing and Health"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRC MR\/S011277\/1, MR\/S005145\/1, MR\/R024901\/1"],"award-info":[{"award-number":["MRC MR\/S011277\/1, MR\/S005145\/1, MR\/R024901\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRC MR\/S011277\/1, MR\/S005145\/1, MR\/R024901\/1"],"award-info":[{"award-number":["MRC MR\/S011277\/1, MR\/S005145\/1, MR\/R024901\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Program 1"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R01AG056850-01A1, R21AG056974, R01AG061566, 1R01AG081394-01, 1R61AG066543-01"],"award-info":[{"award-number":["1R01AG056850-01A1, R21AG056974, R01AG061566, 1R01AG081394-01, 1R61AG066543-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department de Salut de la Generalitat de Catalunya","award":["SLT006\/17\/00119"],"award-info":[{"award-number":["SLT006\/17\/00119"]}]},{"DOI":"10.13039\/501100010805","name":"Fundaci\u00f3n Tatiana P\u00e9rez de Guzm\u00e1n el Bueno","doi-asserted-by":"publisher","award":["IIBSP-DOW-2020-151"],"award-info":[{"award-number":["IIBSP-DOW-2020-151"]}],"id":[{"id":"10.13039\/501100010805","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Horizon 2020\u2013Research and Innovation Framework Programme from the European Union","award":["H2020-SC1-BHC-2018-2020"],"award-info":[{"award-number":["H2020-SC1-BHC-2018-2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Life expectancy for individuals with Down syndrome (DS) has significantly increased, primarily due to medical advances. While DS is considered a genetically determined form of Alzheimer\u2019s disease (DS-AD), with neuropathological markers evident by age 40, the onset of clinical dementia varies. Modifiable risk factors are thought to contribute meaningfully to dementia risk in the general population. Advances in intervention studies in the general population suggest cognitive decline can be reduced through multimodal lifestyle interventions, however no large-scale multimodal studies have been conducted in the DS population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Search strategy<\/jats:title>\n                    <jats:p>A comprehensive search was conducted across five electronic databases\u2014Medline, EMBASE, CINAHL, Web of Science, and ASSIA to identify studies that examined the relationship between lifestyle interventions and cognitive outcomes in adults with DS. The search combined database-specific controlled language with keywords related to exercise, diet, social activities, cardiovascular health, and brain stimulation. Studies included were peer-reviewed original research articles focusing on adults with DS and reported on cognitive outcomes or AD-related biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The search yielded 24,774 articles, with 16,868 remaining after duplicates were removed. A total of 44 articles met inclusion criteria across the domains of exercise, diet, cardiovascular health, social connectedness, and cognitive stimulation. Most studies focused on exercise, indicating some cognitive benefits, particularly in executive functions and working memory, though results were inconsistent, and many suggested the necessity of high adherence to intervention protocols. No studies were found that examined the direct impact of diet on cognition in DS. Findings on cognitive stimulation, cardiovascular health and social connectedness suggested potential but inconclusive benefits for cognitive function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This review underscores the significant gaps in research regarding non-pharmacological interventions for DS-AD. It highlights the need for tailored, well-structured studies to better understand and leverage potential cognitive benefits of lifestyle interventions in the DS population. Implementing such interventions early in life and before significant disease progression may help maintain quality of life and independence among individuals with DS. Future research should focus on comprehensive, multi-domain interventions to ascertain their efficacy and optimal application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11689-026-09694-0","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:18:04Z","timestamp":1776759484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lifestyle intervention and cognitive outcomes in Down syndrome: a horizon 21 European Down syndrome consortium scoping review"],"prefix":"10.1186","volume":"18","author":[{"given":"Eimear","family":"McGlinchey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid H.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Eustace-Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stockbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Baldimtsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Melbye","family":"Langballe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frode Kibsgaard","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Sandk\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Ivain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Rebillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ecrement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McCarron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bessy","family":"Benejam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Ming","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"\u00d6hman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Charlotte","family":"Granholm-Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Strydom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"N\u00fcbling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"2","key":"9694_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","volume":"17","author":"AH Bittles","year":"2007","unstructured":"Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health. 2007;17(2):221\u20135.","journal-title":"Eur J Public Health"},{"issue":"4","key":"9694_CR2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","volume":"163","author":"AP Presson","year":"2013","unstructured":"Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL, et al. Current estimate of Down syndrome population prevalence in the United States. J Pediatr. 2013;163(4):1163\u20138.","journal-title":"J Pediatr"},{"key":"9694_CR3","doi-asserted-by":"crossref","unstructured":"Gensous N, Bacalini MG, Franceschi C, Garagnani P, editors. Down syndrome, accelerated aging and immunosenescence. 2020: Springer.","DOI":"10.1007\/s00281-020-00804-1"},{"issue":"6","key":"9694_CR4","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2468-2667(23)00057-9","volume":"8","author":"RA Baksh","year":"2023","unstructured":"Baksh RA, Pape SE, Chan LF, Aslam AA, Gulliford MC, Strydom A. Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records. Lancet Public Health. 2023;8(6):e453\u201362.","journal-title":"Lancet Public Health"},{"issue":"11","key":"9694_CR5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","volume":"20","author":"J Fortea","year":"2021","unstructured":"Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer\u2019s disease associated with Down syndrome: a genetic form of dementia. Lancet Neurol. 2021;20(11):930\u201342.","journal-title":"Lancet Neurol"},{"issue":"1","key":"9694_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","volume":"6","author":"YS Davidson","year":"2018","unstructured":"Davidson YS, Robinson A, Prasher VP, Mann DMA. The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome. Acta Neuropathol Commun. 2018;6(1):56.","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"9694_CR7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/jir.12390","volume":"61","author":"M McCarron","year":"2017","unstructured":"McCarron M, McCallion P, Reilly E, Dunne P, Carroll R, Mulryan N. A prospective 20-year longitudinal follow\u2010up of dementia in persons with Down syndrome. J Intellect Disabil Res. 2017;61(9):843\u201352.","journal-title":"J Intellect Disabil Res"},{"issue":"10242","key":"9694_CR8","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","volume":"395","author":"J Fortea","year":"2020","unstructured":"Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, Barroeta I, et al. Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: a cross-sectional study. Lancet. 2020;395(10242):1988\u201397.","journal-title":"Lancet"},{"issue":"5","key":"9694_CR9","doi-asserted-by":"crossref","first-page":"e2212910","DOI":"10.1001\/jamanetworkopen.2022.12910","volume":"5","author":"MF Iulita","year":"2022","unstructured":"Iulita MF, Chavez DG, Christensen MK, Tamayo NV, Plana-Ripoll O, Rasmussen SA, et al. Association of Alzheimer disease with life expectancy in people with Down syndrome. JAMA Netw open. 2022;5(5):e2212910\u2013e.","journal-title":"JAMA Netw open"},{"issue":"10452","key":"9694_CR10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. lancet. 2024;404(10452):572\u2013628.","journal-title":"lancet"},{"key":"9694_CR11","doi-asserted-by":"crossref","first-page":"624125","DOI":"10.3389\/fpsyt.2021.624125","volume":"12","author":"J Lehtisalo","year":"2021","unstructured":"Lehtisalo J, Palmer K, Mangialasche F, Solomon A, Kivipelto M, Ngandu T. Changes in lifestyle, behaviors, and risk factors for cognitive impairment in older persons during the first wave of the coronavirus disease 2019 pandemic in Finland: results from the FINGER study. Front Psychiatry. 2021;12:624125.","journal-title":"Front Psychiatry"},{"issue":"9984","key":"9694_CR12","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363.","journal-title":"Lancet"},{"issue":"1","key":"9694_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-023-01355-x","volume":"16","author":"M Barbera","year":"2024","unstructured":"Barbera M, Lehtisalo J, Perera D, Asp\u00f6 M, Cross M, De Jager Loots CA, et al. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol. Alzheimers Res Ther. 2024;16(1):23.","journal-title":"Alzheimers Res Ther"},{"key":"9694_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jar.12369","volume":"30","author":"AV Kenshole","year":"2017","unstructured":"Kenshole AV, Gallichan D, Pahl S, Clibbens J. Lifestyle factors and Alzheimer\u2019s disease in people with Down syndrome. J Appl Res Intellect Disabil. 2017;30:58\u201366.","journal-title":"J Appl Res Intellect Disabil"},{"issue":"9","key":"9694_CR15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3390\/jcm10091882","volume":"10","author":"SE Pape","year":"2021","unstructured":"Pape SE, Baksh RA, Startin C, Hamburg S, Hithersay R, Strydom A. The association between physical activity and CAMDEX-DS changes prior to the onset of Alzheimer\u2019s disease in Down Syndrome. J Clin Med. 2021;10(9):1882.","journal-title":"J Clin Med"},{"key":"9694_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neurobiolaging.2021.07.016","volume":"107","author":"V Fleming","year":"2021","unstructured":"Fleming V, Piro-Gambetti B, Patrick A, Zammit M, Alexander A, Christian BT, et al. Physical activity and cognitive and imaging biomarkers of Alzheimer\u2019s disease in Down syndrome. Neurobiol Aging. 2021;107:118\u201327.","journal-title":"Neurobiol Aging"},{"key":"9694_CR17","doi-asserted-by":"crossref","first-page":"919711","DOI":"10.3389\/fnint.2022.919711","volume":"16","author":"JC Peven","year":"2022","unstructured":"Peven JC, Handen BL, Laymon CM, Fleming V, Piro-Gambetti B, Christian BT, et al. Physical activity, memory function, and hippocampal volume in adults with Down syndrome. Front Integr Nuerosci. 2022;16:919711.","journal-title":"Front Integr Nuerosci"},{"key":"9694_CR18","doi-asserted-by":"crossref","unstructured":"Fleming VL, Peven J, Helsel BC, Ptomey LT, Clina J, Barry A et al. Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions. 2025;11(3):e70127.","DOI":"10.1002\/trc2.70127"},{"issue":"12","key":"9694_CR19","doi-asserted-by":"crossref","first-page":"e28618","DOI":"10.1371\/journal.pone.0028618","volume":"6","author":"AC Phillips","year":"2011","unstructured":"Phillips AC, Holland AJ. Assessment of objectively measured physical activity levels in individuals with intellectual disabilities with and without Down\u2019s syndrome. PLoS ONE. 2011;6(12):e28618.","journal-title":"PLoS ONE"},{"key":"9694_CR20","doi-asserted-by":"crossref","unstructured":"Ringenbach S, Arnold N, Myer B, Hayes C, Nam K, Chen C-C. Executive Function Improves Following Acute Exercise in Adults with Down Syndrome. Brain Sci. 2021;11(5).","DOI":"10.3390\/brainsci11050620"},{"issue":"7","key":"9694_CR21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/jir.12163","volume":"59","author":"CC Chen","year":"2015","unstructured":"Chen CC, Ringenbach SDR, Crews D, Kulinna PH, Amazeen EL. The association between a single bout of moderate physical activity and executive function in young adults with Down syndrome: a preliminary study. J Intellect Disabil Res. 2015;59(7):589\u201398.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"9694_CR22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/jir.12258","volume":"60","author":"CC Chen","year":"2016","unstructured":"Chen CC, Ringenbach SDR. Dose-response relationship between intensity of exercise and cognitive performance in individuals with Down syndrome: a preliminary study. J Intellect Disabil Res. 2016;60(6):606\u201314.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"9694_CR23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jir.12603","volume":"63","author":"CC Chen","year":"2019","unstructured":"Chen CC, Ringenbach SDR. The effect of acute exercise on the performance of verbal fluency in adolescents and young adults with Down syndrome: a pilot study. J Intellect Disabil Res. 2019;63(6):614\u201323.","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"9694_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/brainsci15010002","volume":"15","author":"SDR Ringenbach","year":"2025","unstructured":"Ringenbach SDR, Arnold NE, Rezvani FR, Chen C-C. Cognitive Planning Improved After Cycling Exercise in Older Adults with Down Syndrome. Brain Sci [Internet]. 2025;15(1):2.","journal-title":"Brain Sci [Internet]"},{"issue":"23","key":"9694_CR25","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.3390\/ijerph20237121","volume":"20","author":"V Merzbach","year":"2023","unstructured":"Merzbach V, Ferrandino M, Gernigon M, Marques Pinto J, Scruton A, Gordon D. Impact of Prescribed Exercise on the Physical and Cognitive Health of Adults with Down Syndrome: The MinDSets Study. Int J Environ Res Public Health. 2023;20(23):7121.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"9694_CR26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/jir.12275","volume":"60","author":"SDR Ringenbach","year":"2016","unstructured":"Ringenbach SDR, Holzapfel SD, Mulvey GM, Jimenez A, Benson A, Richter M. The effects of assisted cycling therapy (ACT) and voluntary cycling on reaction time and measures of executive function in adolescents with Down syndrome. J Intellect Disabil Res. 2016;60(11):1073\u201385.","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"9694_CR27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.dhjo.2018.02.003","volume":"11","author":"LT Ptomey","year":"2018","unstructured":"Ptomey LT, Szabo AN, Willis EA, Gorczyca AM, Greene JL, Danon JC, et al. Changes in cognitive function after a 12-week exercise intervention in adults with Down syndrome. Disabil health J. 2018;11(3):486\u201390.","journal-title":"Disabil health J"},{"key":"9694_CR28","doi-asserted-by":"crossref","first-page":"927629","DOI":"10.3389\/fresc.2022.927629","volume":"3","author":"EM Post","year":"2022","unstructured":"Post EM, Kraemer WJ, Kackley ML, Caldwell LK, Volek JS, Sanchez BN, et al. The Effects of Resistance Training on Physical Fitness and Neuromotor-Cognitive Functions in Adults With Down Syndrome. Front rehabilitation Sci. 2022;3:927629.","journal-title":"Front rehabilitation Sci"},{"key":"9694_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ridd.2015.08.003","volume":"45\u201346","author":"SD Holzapfel","year":"2015","unstructured":"Holzapfel SD, Ringenbach SDR, Mulvey GM, Sandoval-Menendez AM, Cook MR, Ganger RO, et al. Improvements in manual dexterity relate to improvements in cognitive planning after assisted cycling therapy (ACT) in adolescents with down syndrome. Res Dev Disabil. 2015;45\u201346:261\u201370.","journal-title":"Res Dev Disabil"},{"issue":"8","key":"9694_CR30","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/20445911.2016.1205592","volume":"28","author":"SD Holzapfel","year":"2016","unstructured":"Holzapfel SD, Ringenbach SDR, Mulvey GM, Sandoval-Menendez AM, Birchfield N, Tahiliani SR. Differential effects of assisted cycling therapy on short-term and working memory of adolescents with Down syndrome. J Cogn Psychol. 2016;28(8):990\u20131003.","journal-title":"J Cogn Psychol"},{"issue":"12","key":"9694_CR31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/jir.12979","volume":"66","author":"N Shields","year":"2022","unstructured":"Shields N, Mizzi N, Buhlert-Smith K, Strydom A, Prendergast L, Hocking DR. A 12\u2010week exercise programme has a positive effect on everyday executive function in young people with Down syndrome: a pilot non\u2010randomised controlled trial. J Intellect Disabil Res. 2022;66(12):924\u201338.","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"9694_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1352\/1944-7558-126.1.34","volume":"126","author":"A Perrot","year":"2021","unstructured":"Perrot A, Maillot P, Le Foulon A, Rebillat A-S. Effect of Exergaming on Physical Fitness, Functional Mobility, and Cognitive Functioning in Adults With Down Syndrome. Am J Intellect Dev Disabil. 2021;126(1):34\u201344.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"3","key":"9694_CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10882-018-9640-y","volume":"31","author":"CC Chen","year":"2019","unstructured":"Chen CC, Ringenbach SDR. Dose-Response Association between Exercise Intensity and Manual Motor Performance in Individuals with Down Syndrome: a Preliminary Study. J Dev Phys Disabil. 2019;31(3):299\u2013311.","journal-title":"J Dev Phys Disabil"},{"issue":"5","key":"9694_CR34","doi-asserted-by":"crossref","first-page":"e70297","DOI":"10.1002\/alz.70297","volume":"21","author":"JG Clina","year":"2025","unstructured":"Clina JG, Danon JC, Helsel BC, Lepping RJ, Martin LE, Sherman JR, et al. The association between cardiorespiratory fitness and resting-state functional connectivity in adults with Down syndrome. Alzheimer\u2019s Dement. 2025;21(5):e70297.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3 Pt 2","key":"9694_CR35","first-page":"450","volume":"85","author":"FR Brown 3rd","year":"1990","unstructured":"Brown FR 3rd, Greer MK, Aylward EH, Hunt HH. Intellectual and adaptive functioning in individuals with Down syndrome in relation to age and environmental placement. Pediatrics. 1990;85(3 Pt 2):450\u20132.","journal-title":"Pediatrics"},{"key":"9694_CR36","doi-asserted-by":"crossref","unstructured":"Harisinghani A, Dhand A, Steffensen EH, Skotko BG. Sustainability of personal social networks of people with Down syndrome. American journal of medical genetics Part C, Seminars in medical genetics. 2023:e32064.","DOI":"10.1002\/ajmg.c.32064"},{"issue":"3","key":"9694_CR37","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/ajmg.a.63059","volume":"191","author":"BG Skotko","year":"2023","unstructured":"Skotko BG, Krell K, Haugen K, Torres A, Nieves A, Dhand A. Personal social networks of people with Down syndrome. Am J Med Genet Part A. 2023;191(3):690\u20138.","journal-title":"Am J Med Genet Part A"},{"key":"9694_CR38","doi-asserted-by":"crossref","unstructured":"Mihaila I, Handen BL, Christian BT, Hartley SL. Leisure activity in middle-aged adults with Down syndrome: Initiators, social partners, settings and barriers. Journal Of Applied Research In Intellectual Disabilities. 2020;33(5):865\u201375.","DOI":"10.1111\/jar.12706"},{"issue":"7","key":"9694_CR39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/dneu.22677","volume":"79","author":"I Mihaila","year":"2019","unstructured":"Mihaila I, Handen BL, Christian BT, Lao PJ, Cody KA, Klunk WE, et al. Leisure Activity, Brain \u03b2-amyloid, and Episodic Memory in Adults with Down Syndrome. Dev Neurobiol. 2019;79(7):738\u201349.","journal-title":"Dev Neurobiol"},{"issue":"4","key":"9694_CR40","doi-asserted-by":"crossref","first-page":"e70109","DOI":"10.1111\/jar.70109","volume":"38","author":"EK Schworer","year":"2025","unstructured":"Schworer EK, Zammit MD, Handen BL, Piro-Gambetti B, Jenkins MR, Brothers C, et al. Lifestyle Composite and Resilience to Alzheimer\u2019s Disease Pathology in Down Syndrome. J Appl Res Intellect Disabil. 2025;38(4):e70109.","journal-title":"J Appl Res Intellect Disabil"},{"issue":"9","key":"9694_CR41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/jir.12626","volume":"63","author":"E McGlinchey","year":"2019","unstructured":"McGlinchey E, McCarron M, Holland A, McCallion P. Examining the effects of computerised cognitive training on levels of executive function in adults with Down syndrome. J Intellect Disabil research: JIDR. 2019;63(9):1137\u201350.","journal-title":"J Intellect Disabil research: JIDR"},{"issue":"1","key":"9694_CR42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1162\/netn_a_00177","volume":"5","author":"A Anagnostopoulou","year":"2021","unstructured":"Anagnostopoulou A, Styliadis C, Kartsidis P, Romanopoulou E, Zilidou V, Karali C, et al. Computerized physical and cognitive training improves the functional architecture of the brain in adults with Down syndrome: A network science EEG study. Netw Neurosci. 2021;5(1):274\u201394.","journal-title":"Netw Neurosci"},{"issue":"4","key":"9694_CR43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/13607863.2020.1869180","volume":"26","author":"A Ali","year":"2022","unstructured":"Ali A, Brown E, Tsang W, Spector A, Aguirre E, Hoare S, et al. Individual cognitive stimulation therapy (iCST) for people with intellectual disability and dementia: a feasibility randomised controlled trial. Aging Ment Health. 2022;26(4):698\u2013708.","journal-title":"Aging Ment Health"},{"issue":"8","key":"9694_CR44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","volume":"15","author":"R de la Torre","year":"2016","unstructured":"de la Torre R, de Sola S, Hernandez G, Farr\u00e9 M, Pujol J, Rodriguez J, et al. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down\u2019s syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15(8):801\u201310.","journal-title":"Lancet Neurol"},{"key":"9694_CR45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-018-1866-3","volume":"136","author":"DMA Mann","year":"2018","unstructured":"Mann DMA, Davidson YS, Robinson AC, Allen N, Hashimoto T, Richardson A, et al. Patterns and severity of vascular amyloid in Alzheimer\u2019s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 2018;136:569\u201387.","journal-title":"Acta Neuropathol"},{"key":"9694_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0499-4","volume":"5","author":"E Head","year":"2017","unstructured":"Head E, Phelan MJ, Doran E, Kim RC, Poon WW, Schmitt FA, et al. Cerebrovascular pathology in Down syndrome and Alzheimer disease. Acta Neuropathol Commun. 2017;5:1\u20139.","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"9694_CR47","first-page":"P1193","volume":"13","author":"JM Artal","year":"2017","unstructured":"Artal JM, Sherzai AZ, Sherzai D. High prevalence of vascular and metabolic risk factors among down syndrome patients with Alzheimer\u2019s disease: A survey report of the national down syndrome registry (DS-connect). Alzheimer\u2019s Dement. 2017;13(7):P1193\u20134.","journal-title":"Alzheimer\u2019s Dement"},{"key":"9694_CR48","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ijcard.2015.11.041","volume":"203","author":"DL Vetrano","year":"2016","unstructured":"Vetrano DL, Carf\u00ec A, Brandi V, L\u2019Angiocola PD, Di Tella S, Cipriani MC, et al. Left ventricle diastolic function and cognitive performance in adults with Down syndrome. Int J Cardiol. 2016;203:816\u20138.","journal-title":"Int J Cardiol"},{"issue":"4","key":"9694_CR49","doi-asserted-by":"crossref","first-page":"101497","DOI":"10.1016\/j.dhjo.2023.101497","volume":"16","author":"D Dodd","year":"2023","unstructured":"Dodd D, Helsel B, Bodde AE, Danon JC, Sherman JR, Donnelly JE, et al. The association of increased body mass index on cardiorespiratory fitness, physical activity, and cognition in adults with down syndrome. Disabil health J. 2023;16(4):101497.","journal-title":"Disabil health J"},{"key":"9694_CR50","doi-asserted-by":"crossref","unstructured":"Huang YN, Huang JY, Wang CH, Su PH. Long-Term Non-Congenital Cardiac and Renal Complications in Down Syndrome: A Study of 32,936 Patients. Children. 2023;10(8).","DOI":"10.3390\/children10081351"},{"key":"9694_CR51","doi-asserted-by":"crossref","unstructured":"Lai F, Mercaldo N, Wang CM, Hersch GG, Rosas HD. Association between Inflammatory Conditions and Alzheimer\u2019s Disease Age of Onset in Down Syndrome. J Clin Med. 2021;10(14).","DOI":"10.3390\/jcm10143116"},{"issue":"2","key":"9694_CR52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0197-4580(03)00089-7","volume":"25","author":"BN Patel","year":"2004","unstructured":"Patel BN, Pang D, Stern Y, Silverman W, Kline JK, Mayeux R, et al. Obesity enhances verbal memory in postmenopausal women with Down syndrome. Neurobiol Aging. 2004;25(2):159\u201366.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"9694_CR53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/20473869.2017.1301023","volume":"66","author":"ME Percy","year":"2020","unstructured":"Percy ME, Lukiw WJ. Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary. Int J Dev Disabil. 2020;66(1):22\u201335.","journal-title":"Int J Dev Disabil"},{"issue":"9","key":"9694_CR54","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/gps.2014","volume":"23","author":"VP Prasher","year":"2008","unstructured":"Prasher VP, Airuehia E, Patel A, Haque MS. Total serum cholesterol levels and Alzheimer\u2019s dementia in patients with Down syndrome. Int J Geriatr Psychiatry. 2008;23(9):937\u201342.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"9694_CR55","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1352\/1944-7558-123.6.514","volume":"123","author":"TC Rosser","year":"2018","unstructured":"Rosser TC, Edgin JO, Capone GT, Hamilton DR, Allen EG, Dooley KJ, et al. Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition Project. Am J Intellect Dev Disabil. 2018;123(6):514\u201328.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"1","key":"9694_CR56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11689-019-9306-9","volume":"12","author":"CM Startin","year":"2020","unstructured":"Startin CM, D\u2019Souza H, Ball G, Hamburg S, Hithersay R, Hughes KMO, et al. Health comorbidities and cognitive abilities across the lifespan in Down syndrome. J neurodevelopmental disorders. 2020;12(1):4.","journal-title":"J neurodevelopmental disorders"},{"key":"9694_CR57","first-page":"1","volume":"17","author":"S-A Cooper","year":"2016","unstructured":"Cooper S-A, Ademola T, Caslake M, Douglas E, Evans J, Greenlaw N, et al. Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial. Trials. 2016;17:1\u201316.","journal-title":"Trials"},{"issue":"1","key":"9694_CR58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s11689-023-09510-z","volume":"15","author":"L Frank","year":"2023","unstructured":"Frank L, Helsel B, Dodd D, Bodde AE, Danon JC, Sherman JR, et al. The association between cardiovascular health and cognition in adults with Down syndrome. J Neurodevelopmental Disorders. 2023;15(1):43.","journal-title":"J Neurodevelopmental Disorders"},{"key":"9694_CR59","doi-asserted-by":"crossref","unstructured":"Clina JG, Helsel BC, Hartley SL, White DA, Fleming-Batayneh VL, Handen B et al. The impact of congenital heart disease on the timing of Alzheimer\u2019s disease in Down syndrome. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(1):e70257.","DOI":"10.1002\/dad2.70257"},{"issue":"2","key":"9694_CR60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7322\/jhgd.v30.9968","volume":"30","author":"M Almeida EWd, Greguol","year":"2020","unstructured":"Almeida EWd, Greguol M. Lipid profile in people with Down syndrome: A literature review. J Hum Growth Dev. 2020;30(2):197\u2013208.","journal-title":"J Hum Growth Dev"},{"issue":"9","key":"9694_CR61","doi-asserted-by":"crossref","first-page":"e0137093","DOI":"10.1371\/journal.pone.0137093","volume":"10","author":"CG Sobey","year":"2015","unstructured":"Sobey CG, Judkins CP, Sundararajan V, Phan TG, Drummond GR, Srikanth VK. Risk of major cardiovascular events in people with Down syndrome. PLoS ONE. 2015;10(9):e0137093.","journal-title":"PLoS ONE"},{"issue":"1","key":"9694_CR62","doi-asserted-by":"crossref","first-page":"15872","DOI":"10.1038\/s41598-020-72678-0","volume":"10","author":"JH Cho","year":"2020","unstructured":"Cho JH, Choi E-K, Moon I-K, Jung J-H, Han K-D, Choi Y-J, et al. Chromosomal abnormalities and atrial fibrillation and ischemic stroke incidence: a nationwide population-based study. Sci Rep. 2020;10(1):15872.","journal-title":"Sci Rep"},{"key":"9694_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11689-019-9279-8","volume":"11","author":"S Hamburg","year":"2019","unstructured":"Hamburg S, Lowe B, Startin CM, Padilla C, Coppus A, Silverman W, et al. Assessing general cognitive and adaptive abilities in adults with Down syndrome: A systematic review. J neurodevelopmental disorders. 2019;11:1\u201316.","journal-title":"J neurodevelopmental disorders"},{"key":"9694_CR64","first-page":"1","volume":"Preprint","author":"SL Hartley","year":"2023","unstructured":"Hartley SL, Fleming V, Schworer EK, Peven J, Handen BL, Krinsky-McHale S, et al. Timing of Alzheimer\u2019s disease by intellectual disability level in Down syndrome. J Alzheimers Dis. 2023;Preprint:1\u201313.","journal-title":"J Alzheimers Dis"},{"issue":"S3","key":"9694_CR65","doi-asserted-by":"crossref","first-page":"e099395","DOI":"10.1002\/alz70857_099395","volume":"21","author":"C Brothers","year":"2025","unstructured":"Brothers C, Wisch JK, Handen BL, Lao PJ, Ances B, Kennedy JT, et al. Cardiovascular Risk Composite and Time of Amyloid Accumulation and Cognitive Decline in Down Syndrome Alzheimer\u2019s Disease. Alzheimer\u2019s Dement. 2025;21(S3):e099395.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"9694_CR66","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/alz.13365","volume":"20","author":"LD Baker","year":"2024","unstructured":"Baker LD, Snyder HM, Espeland MA, Whitmer RA, Kivipelto M, Woolard N, et al. Study design and methods: US study to protect brain health through lifestyle intervention to reduce risk (US POINTER). Alzheimer\u2019s Dement. 2024;20(2):769\u201382.","journal-title":"Alzheimer\u2019s Dement"},{"key":"9694_CR67","first-page":"1097","volume":"10","author":"A Soltani","year":"2022","unstructured":"Soltani A, Schworer EK, Amin R, Hoffman EK, Esbensen AJ. Executive Functioning, Language, and Behavioral Abilities Related to Obstructive Sleep Apnea in Down Syndrome. J Dev Behav Pediatr. 2022;10:1097.","journal-title":"J Dev Behav Pediatr"},{"issue":"14","key":"9694_CR68","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.3390\/jcm10143012","volume":"10","author":"S Gim\u00e9nez","year":"2021","unstructured":"Gim\u00e9nez S, Altuna M, Blessing E, Osorio RM, Fortea J. Sleep disorders in adults with Down syndrome. J Clin Med. 2021;10(14):3012.","journal-title":"J Clin Med"},{"issue":"6","key":"9694_CR69","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.ridd.2013.03.009","volume":"34","author":"CCJ Chen","year":"2013","unstructured":"Chen CCJ, Span\u00f2 G, Edgin JO. The impact of sleep disruption on executive function in Down syndrome. Res Dev Disabil. 2013;34(6):2033\u20139.","journal-title":"Res Dev Disabil"},{"issue":"1","key":"9694_CR70","doi-asserted-by":"crossref","first-page":"zpac013","DOI":"10.1093\/sleepadvances\/zpac013","volume":"3","author":"P Lao","year":"2022","unstructured":"Lao P, Zimmerman ME, Hartley SL, Gutierrez J, Keator D, Igwe KC, et al. Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer\u2019s continuum. Sleep Adv. 2022;3(1):zpac013.","journal-title":"Sleep Adv"},{"issue":"10","key":"9694_CR71","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.5664\/jcsm.7382","volume":"14","author":"S Gim\u00e9nez","year":"2018","unstructured":"Gim\u00e9nez S, Videla L, Romero S, Benejam B, Clos S, Fern\u00e1ndez S, et al. Prevalence of sleep disorders in adults with down syndrome: a comparative study of self-reported, actigraphic, and polysomnographic findings. J Clin Sleep Med. 2018;14(10):1725\u201333.","journal-title":"J Clin Sleep Med"},{"key":"9694_CR72","doi-asserted-by":"crossref","first-page":"104302","DOI":"10.1016\/j.ridd.2022.104302","volume":"129","author":"MA Alma","year":"2022","unstructured":"Alma MA, Nijenhuis-Huls R, de Jong Z, Ulgiati AM, de Vries A, Dekker AD. Detecting sleep apnea in adults with Down syndrome using WatchPAT: A feasibility study. Res Dev Disabil. 2022;129:104302.","journal-title":"Res Dev Disabil"},{"issue":"12","key":"9694_CR73","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.2337\/dc22-0482","volume":"45","author":"AA Aslam","year":"2022","unstructured":"Aslam AA, Baksh RA, Pape SE, Strydom A, Gulliford MC, Chan LF, et al. Diabetes and obesity in Down syndrome across the lifespan: A retrospective cohort study using UK electronic health records. Diabetes Care. 2022;45(12):2892\u20139.","journal-title":"Diabetes Care"},{"issue":"10","key":"9694_CR74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Reviews Endocrinol. 2018;14(10):591\u2013604.","journal-title":"Nat Reviews Endocrinol"},{"key":"9694_CR75","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00508-015-0750-6","volume":"127","author":"A Dressler","year":"2015","unstructured":"Dressler A, Bozza M, Perelli V, Tinelli F, Guzzetta A, Cioni G, et al. Vision problems in Down syndrome adults do not hamper communication, daily living skills and socialisation. Wiener klinische Wochenschrift. 2015;127:594\u2013600.","journal-title":"Wiener klinische Wochenschrift"},{"issue":"8","key":"9694_CR76","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.ophtha.2003.12.051","volume":"111","author":"J van Splunder","year":"2004","unstructured":"van Splunder J, Stilma JS, Bernsen RMD, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology. 2004;111(8):1457\u201363.","journal-title":"Ophthalmology"},{"key":"9694_CR77","doi-asserted-by":"crossref","unstructured":"Malt EA, Dahl RC, Haugsand TM, Ulvestad IH, Emilsen NM, Hansen B, et al. Health and disease in adults with Down syndrome. Tidsskrift for Den norske legeforening; 2013.","DOI":"10.4045\/tidsskr.12.0390"},{"issue":"7","key":"9694_CR78","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2788.2005.00704.x","volume":"49","author":"M McCarron","year":"2005","unstructured":"McCarron M, Gill M, McCallion P, Begley C. Health co-morbidities in ageing persons with Down syndrome and Alzheimer\u2019s dementia. J Intellect Disabil Res. 2005;49(7):560\u20136.","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"9694_CR79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nrleng.2014.12.019","volume":"32","author":"JS Aller-Alvarez","year":"2017","unstructured":"Aller-Alvarez JS, Men\u00e9ndez-Gonz\u00e1lez M, Ribacoba-Montero R, Salvado M, Vega V, Su\u00e1rez-Moro R, et al. Myoclonic epilepsy in Down syndrome and Alzheimer disease. Neurolog\u00eda (English Edition). 2017;32(2):69\u201373.","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"9694_CR80","doi-asserted-by":"crossref","unstructured":"Krinsky-McHale SJ, Hartley S, Hom C, Pulsifer M, Clare ICH, Handen BL et al. A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2022;14(1):e12361.","DOI":"10.1002\/dad2.12361"},{"issue":"3","key":"9694_CR81","doi-asserted-by":"crossref","first-page":"e70071","DOI":"10.1002\/alz.70071","volume":"21","author":"P Ivain","year":"2025","unstructured":"Ivain P, Baksh A, Saini F, Idris M, Tamayo-Elizalde M, Wells J, et al. Validation of the CAMCOG\u2010DS\u2010II, a neuropsychological test battery for Alzheimer\u2019s disease in people with Down syndrome: a Horizon 21 European Down syndrome Consortium study. Alzheimer\u2019s Dement. 2025;21(3):e70071.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"9694_CR82","first-page":"439","volume":"19","author":"G De Graaf","year":"2017","unstructured":"De Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Sci. 2017;19(4):439\u201347.","journal-title":"Genet Sci"},{"issue":"3","key":"9694_CR83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41431-020-00748-y","volume":"29","author":"G de Graaf","year":"2021","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in Europe. Eur J Hum Genet. 2021;29(3):402\u201310.","journal-title":"Eur J Hum Genet"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-026-09694-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:28:32Z","timestamp":1781648912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11689-026-09694-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9694"],"URL":"https:\/\/doi.org\/10.1186\/s11689-026-09694-0","relation":{},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}